<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2025 20_1-2_28-9</article-id>
<article-id pub-id-type="doi">10.15836/ccar2025.28</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Structural Heart Disease Interventions</subject></subj-group>
</article-categories>
<title-group>
<article-title>Introducing the transcaval transcatheter aortic valve implantation to Croatia: pioneering experience from Split</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9272-6906</contrib-id><name><surname>Mateti&#x0107;</surname><given-names>Andrija</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6639-5971</contrib-id><name><surname>Runji&#x0107;</surname><given-names>Frane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1399-3406</contrib-id><name><surname>Crn&#x010D;evi&#x0107;</surname><given-names>Nikola</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9882-9145</contrib-id><name><surname>Kristi&#x0107;</surname><given-names>Ivica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6751-5242</contrib-id><name><surname>Bakovi&#x0107; Kramari&#x0107;</surname><given-names>Darija</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital of Split</institution>, <addr-line>Split</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Split School of Medicine</institution>, <addr-line>Split</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Andrija Mateti&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Split, Spin&#x010D;iceva 1, HR-21000 Split, Croatia. / Phone: +385-98-9546-455 / E-mail: <email xlink:href="andrija.matetic@gmail.com">andrija.matetic@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>03</month><year>2025</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>03</month><year>2025</year></pub-date>
<volume>20</volume>
<issue>1-2</issue>
<fpage>28</fpage>
<lpage>29</lpage>
<history>
<date date-type="received"><day>05</day><month>02</month><year>2025</year></date>
<date><day>14</day><month>02</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>transcaval approach</kwd><kwd>transcatheter aortic valve implantation</kwd><kwd>pioneering</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Transcatheter aortic valve implantation (TAVI) is a life-saving procedure for patients with severe symptomatic aortic stenosis at high surgical risk. The transfemoral approach is preferred, but some patients have unsuitable iliofemoral arteries, necessitating alternative access (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). While no consensus exists on the best alternative, the transcaval approach offers advantages when performed in experienced centers (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>, <xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). Compared to transaxillary or transcarotid access, transcaval TAVI lowers stroke risk, allows easier valve deployment, accommodates any sheath size, is fully percutaneous, and maintains a transfemoral-like setup (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>, <xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). This study presents the first transcaval TAVI cases in Croatia and Central-Southeast Europe, successfully performed at the University Hospital of Split. Six cases were completed, with one exemplary case detailed here.</p>
<p><bold>Case report</bold>: 78-year-old male with severe symptomatic aortic stenosis and high surgical risk was referred for TAVI. His history included chronic heart failure, chronic kidney disease with a functional kidney transplant, severe peripheral artery disease, prior carotid surgery, stroke, and cancer treatment. Due to extensive iliofemoral calcification and prior kidney transplant attachment, the transfemoral approach was unfeasible (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>). Transaxillary access was also ruled out due to significant stenoses. The Structural Heart Team opted for the transcaval approach after detailed preprocedural planning (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>). The fully percutaneous procedure was performed under operator-led sedation. The tract between the inferior vena cava and abdominal aorta was created using an electrified wire and snare, followed by eSheath (16F) placement. An Edwards Sapien S3 Ultra 29 mm valve was deployed successfully, achieving optimal positioning and no regurgitation. The tract was sealed using an Amplatzer Duct Occluder, and vascular access was closed with suture devices (<xref ref-type="fig" rid="f3"><bold>Figure 3</bold></xref>). The patient recovered uneventfully and was discharged on postoperative day 3.</p>
<fig id="f1" position="float" fig-type="figure"><label>FIGURE 1</label><caption><p>Computed tomography reconstructions of iliofemoral arteries: Severe bilateral atherosclerosis and calcifications with a functional kidney donor on the right side.</p></caption><graphic xlink:href="CC202520_1-2_28-9-f1"></graphic></fig>
<fig id="f2" position="float" fig-type="figure"><label>FIGURE 2</label><caption><p>Procedural planning using the multiplanar and 3-dimensional reconstructions: Complete planning was done internally by the operators within the University Hospital of Split.</p></caption><graphic xlink:href="CC202520_1-2_28-9-f2"></graphic></fig>
<fig id="f3" position="float" fig-type="figure"><label>FIGURE 3</label><caption><p>Procedural execution and steps (A-F): All procedures were done without the proctors, after advanced international education.</p></caption><graphic xlink:href="CC202520_1-2_28-9-f3"></graphic></fig>
<p><bold>Conclusion</bold>: Transcaval TAVI is a viable alternative for patients with unsuitable iliofemoral anatomy. It can be achieved with favourable procedural outcomes, if preceded by meticulous preprocedural planning and performed by experienced operators.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahanian</surname><given-names>A</given-names></name><name><surname>Beyersdorf</surname><given-names>F</given-names></name><name><surname>Praz</surname><given-names>F</given-names></name><name><surname>Milojevic</surname><given-names>M</given-names></name><name><surname>Baldus</surname><given-names>S</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name><etal/><collab>ESC/EACTS Scientific Document Group</collab></person-group>. <article-title>2021 ESC/EACTS Guidelines for the management of valvular heart disease.</article-title> <source>Eur Heart J</source>. <year>2022</year> February 12;<volume>43</volume>(<issue>7</issue>):<fpage>561</fpage>&#x2013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehab395</pub-id><pub-id pub-id-type="pmid">34453165</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salihu</surname><given-names>A</given-names></name><name><surname>Ferlay</surname><given-names>C</given-names></name><name><surname>Kirsch</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>PB</given-names></name><name><surname>Skali</surname><given-names>H</given-names></name><name><surname>Fournier</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Outcomes and Safety of Transcaval Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis.</article-title> <source>Can J Cardiol</source>. <year>2024</year> November;<volume>40</volume>(<issue>11</issue>):<fpage>2054</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjca.2024.05.016</pub-id><pub-id pub-id-type="pmid">38797283</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederman</surname><given-names>RJ</given-names></name><name><surname>Babaliaros</surname><given-names>VC</given-names></name><name><surname>Lisko</surname><given-names>JC</given-names></name><name><surname>Rogers</surname><given-names>T</given-names></name><name><surname>Mahoney</surname><given-names>P</given-names></name><name><surname>Foerst</surname><given-names>JR</given-names></name><etal/></person-group> <article-title>Transcaval Versus Transaxillary TAVR in Contemporary Practice: A Propensity-Weighted Analysis.</article-title> <source>JACC Cardiovasc Interv</source>. <year>2022</year> May 9;<volume>15</volume>(<issue>9</issue>):<fpage>965</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcin.2022.03.014</pub-id><pub-id pub-id-type="pmid">35512920</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
